Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1222, 2008-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Greater long-term CV risk reduction with intensive insulin therapy
Inpharma, Vol. 1, Iss. 1520, 2006-01 ,pp. :
Access to resources
Recommend
Sulfonylureas show unfavourable risk profiles
Reactions Weekly, Vol. 1, Iss. 1283, 2010-01 ,pp. :
Metformin linked to fewer CV events, deaths than sulfonylureas
Reactions Weekly, Vol. 1, Iss. 1429, 2012-01 ,pp. :
Increased CV risk with glucocorticoids in Cushing's
Reactions Weekly, Vol. 1, Iss. 1413, 2012-01 ,pp. :
Hospitalisation rates, LOS for CV disorders in Canada
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 440, 2003-01 ,pp. :